Search clinical trials for: opioid consumption

Total 8286 results

Purdue Pharma LP

Completed

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

Osteoarthritis

United States
Purdue Pharma LP

Completed

The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Chronic Back Pain.

Chronic Low Back Pain

United States
Purdue Pharma LP

Completed

Safety and Effectiveness of Buprenorphine Transdermal System in Elderly Subjects With Chronic Pain: Pilot Study.

Chronic Pain

United States
Purdue Pharma LP

Completed

Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

Osteoarthritis

United States
Purdue Pharma LP

Completed

Safety of the Buprenorphine Transdermal Delivery System in Subjects With Mod-to-Sev Pain Following Orthopedic Surgery.

Postoperative Pain

United States
University Health Network, Toronto
Canadian Institutes of Health Research (CIHR)

Unknown

Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy

Pain | Prostate Cancer | Hyperalgesia

Canada
Montefiore Medical Center

Completed

A Trial Comparing Different Dosing Regimens of Morphine in Patients With Moderate to Severe Pain

Pain

United States
MetaPhore Pharmaceuticals

Terminated

Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain

Pain | Cancer
University of Texas Southwestern Medical Center

Completed

Impact of Low Dose Naloxone on Fentanyl Requirements in Pediatric ICU Patients

Opioid Tolerance

United States
National Health Research Institutes, Taiwan
Bureau of Health Promotion,DoH,Taiwan

Completed

Analysis of 'Tobacco and Alcohol Tax Law' and Its Impact on Cigarette Consumption

Smoking Status | Cigarette Consumption
National Taiwan University Hospital

Unknown

Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography

Liver Disease

Taiwan
National Taiwan University Hospital

Unknown

Interaction Between Nalbuphine and Morphine in PCA

Postoperative Pain

Taiwan
Assistance Publique - Hôpitaux de Paris

Unknown

Bispectral Index as an Analgesia Monitoring in Severely Ill Patient: Effect of Remifentanyl

Pain

France
Royal Liverpool University Hospital

Unknown

Pain Relief - Tramadol Versus Ibuprofen

Melanoma | Eye Neoplasms | Choroidal Melanoma

United Kingdom
National Institute on Drug Abuse (NIDA)

Completed

Study Comparing Liquid and Tablet Buprenorphine Formulations - 5

Heroin Dependence

United States
Organization to Achieve Solutions in Substance...

Unknown

Integrating Buprenorphine Into HIV Treatment

HIV Infections | Opiate Dependence

United States
Khon Kaen University

Completed

Pre-Emptive Analgesia Efficacy of Etoricoxib for Postoperative Pain

a Single-Dose of Etoricoxib | Post-Operative Morphine Consumption | Total Pain Relief Over 8 Hr(TOPAR8) | Post Transabdominal Hysterectomy

Thailand
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification - BBDVI - 19

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Combination Tablet Feasibility - 1

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 18

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Pharmacology Related to Addiction Treatment - 21

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase X - 15

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate Day Buprenorphine Administration, Phase XII - 17

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Buprenorphine Detox With Two Types of Treatment. BBD I - 10

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Methadone/Buprenorphine Cross-Over Study - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Dosing Interval - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase I - 3

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine. Phase V - 6

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase II - 4

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VII - 8

Opioid-Related Disorders

United States
U.S. Bioscience
Jacobus Pharmaceutical

Completed

Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
National Center for Research Resources (NCRR)
Johns Hopkins University; National Institute of Neurological Disorders and...

Completed

Phase III Randomized Controlled Study of Morphine and Nortriptyline in the Management of Postherpetic Neuralgia

Pain | Herpes Zoster
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase IV - 5

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Alternate-Day Buprenorphine Administration. Phase VI - 7

Opioid-Related Disorders

United States
National Institute on Drug Abuse (NIDA)
University of Vermont

Completed

Gradual Vs. Rapid Buprenorphine Detoxification - 2

Opioid-Related Disorders

United States

Search clinical trials for: opioid consumption

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mali

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations